Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$0.45 - $0.86 $2,115 - $4,042
4,700 Added 50.78%
13,955 $7,000
Q3 2022

Nov 04, 2022

SELL
$0.46 - $0.63 $2,162 - $2,961
-4,701 Reduced 33.68%
9,255 $4,000
Q2 2022

Aug 03, 2022

SELL
$0.47 - $0.87 $1,464 - $2,710
-3,116 Reduced 18.25%
13,956 $8,000
Q3 2021

Oct 28, 2021

SELL
$2.91 - $4.83 $20 - $33
-7 Reduced 0.04%
17,072 $76,000
Q2 2021

Aug 12, 2021

BUY
$4.17 - $5.74 $71,219 - $98,033
17,079 New
17,079 $79,000
Q4 2020

Feb 02, 2021

SELL
$5.75 - $7.13 $43,498 - $53,938
-7,565 Closed
0 $0
Q3 2020

Oct 14, 2020

SELL
$4.9 - $7.12 $99,572 - $144,685
-20,321 Reduced 72.87%
7,565 $46,000
Q2 2020

Jul 13, 2020

BUY
$6.43 - $9.86 $24,118 - $36,984
3,751 Added 15.54%
27,886 $202,000
Q1 2020

Apr 29, 2020

SELL
$6.36 - $10.05 $239,244 - $378,050
-37,617 Reduced 60.92%
24,135 $167,000
Q4 2019

Feb 05, 2020

BUY
$8.49 - $12.81 $524,274 - $791,043
61,752 New
61,752 $544,000
Q3 2019

Oct 15, 2019

SELL
$5.58 - $14.47 $16,740 - $43,410
-3,000 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$5.22 - $9.08 $113,242 - $196,981
-21,694 Reduced 87.85%
3,000 $18,000
Q1 2019

Apr 18, 2019

BUY
$5.35 - $9.82 $132,112 - $242,495
24,694 New
24,694 $0
Q2 2018

Jul 30, 2018

SELL
$13.3 - $17.45 $91,051 - $119,462
-6,846 Closed
0 $0
Q1 2018

Apr 26, 2018

SELL
$14.7 - $24.95 $199,376 - $338,396
-13,563 Reduced 66.46%
6,846 $109,000
Q4 2017

Jan 10, 2018

BUY
$19.9 - $29.25 $299,495 - $440,212
15,050 Added 280.84%
20,409 $473,000
Q3 2017

Oct 25, 2017

BUY
$15.1 - $19.25 $80,920 - $103,160
5,359
5,359 $98,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.